Our objective was to describe the health-related quality of life (HRQoL) of individuals with diabetes with and without motility-related upper gastrointestinal symptoms compared to individuals without diabetes. A total of 483 individuals with diabetes and 422 age- and gender-matched nondiabetic controls were recruited from a prior US national health survey for a telephone interview on upper gastrointestinal symptoms. Individuals with diabetes self-reported a physician's diagnosis of diabetes and provided confirming information on clinical management measures. Subjects were asked about upper gastrointestinal symptoms in the month before interview using an instrument with demonstrated high reliability. HRQoL was measured using the SF-12 Health Survey. Individuals with diabetes reporting upper gastrointestinal symptoms scored significantly lower in HRQoL measures of physical health and mental health than either individuals with diabetes who did not report upper gastrointestinal symptoms or individuals without diabetes (P < 0.0001). Individuals with diabetes and no upper gastrointestinal symptoms had physical and mental health summary scores similar to those of individuals without diabetes. Early satiety was the strongest predictor (P < 0.0001) of differences in physical health scores between individuals with and without diabetes. Nausea was the strongest predictor (P < 0.0001) of differences in mental health scores between individuals with and without diabetes. In conclusion, this is the first US national survey to demonstrate that motility-related upper gastrointestinal symptoms are associated with a significantly lower quality of life in individuals with diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1014723525911DOI Listing

Publication Analysis

Top Keywords

individuals diabetes
48
upper gastrointestinal
32
gastrointestinal symptoms
32
diabetes
14
quality life
12
motility-related upper
12
individuals
12
mental health
12
scores individuals
12
diabetes motility-related
8

Similar Publications

The unintended consequences of polypharmacy pose significant risks to older adults. The complexities of managing numerous medications from multiple prescribers demand a comprehensive approach to mitigate harms. Pharmacist-led clinics have been shown to improve outcomes in patients with diabetes and hypertension.

View Article and Find Full Text PDF

Theranostic drugs represent an emerging path to deliver on the promise of precision medicine. However, bottlenecks remain in characterizing theranostic targets, identifying theranostic lead compounds, and tailoring theranostic drugs. To overcome these bottlenecks, we present the Theranostic Genome, the part of the human genome whose expression can be utilized to combine therapeutic and diagnostic applications.

View Article and Find Full Text PDF

Wearable non-invasive neuroprosthesis for targeted sensory restoration in neuropathy.

Nat Commun

December 2024

Neuroengineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Peripheral neuropathy (PN), the most common complication of diabetes, leads to sensory loss and associated health issues as pain and increased fall risk. However, present treatments do not counteract sensory loss, but only partially manage its consequences. Electrical neural stimulation holds promise to restore sensations, but its efficacy and benefits in PN damaged nerves are yet unknown.

View Article and Find Full Text PDF

No study has examined the association between dietary insulin load (DIL) and insulin index (DII) with developing gestational diabetes mellitus (GDM) during pregnancy. This study aimed to investigate the association between DIL and DII and risk of GDM in a group of pregnant women in Iran. In this prospective cohort study, 812 pregnant in their first trimester were recruited and followed.

View Article and Find Full Text PDF

The mechanism(s) underlying gut microbial metabolite (GMM) contribution towards alcohol-mediated cardiovascular disease (CVD) is unknown. Herein we observe elevation in circulating phenylacetylglutamine (PAGln), a known CVD-associated GMM, in individuals living with alcohol use disorder. In a male murine binge-on-chronic alcohol model, we confirm gut microbial reorganization, elevation in PAGln levels, and the presence of cardiovascular pathophysiology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!